Acetate concentrate for haemodialysis CHD-1
 |
Max. value paid with public resources:
Processing
|
 |
Data for med. device |
|
10IIbV1164142653 |
|
13/06/2013 10:49 |
|
13/06/2013 10:58 |
|
12/06/2013 14:38 |
 | Identification of the manufacturer |
|
UNIPHARM AD
|
|
UNIPHARM AD
|
|
Traiko Stanoev 3 |
|
Rositsa Balkandzhyiska |
 | Identification of the person placing the product on the market |
|
UNIPHARM AD
|
|
Traiko Stanoev 3 |
|
Rositsa Balkandzhyiska |
 | General medical information about the device |
|
10 - Single-use devices |
|
Class b |
|
Concentrates for haemodialysis |
|
Acetate concentrate for haemodialysis CHD-1 |
 | Description of the medical device |
|
Na+; K+; Ca2+; Mg2+; Cl-; CH3COO¯; Glucosa |
|
Hospital prescription |
 | Intended action by the manufacturer |
|
CHD-1 is indicated for patients on haemodialysis with acute and chronic renal failure and diabetes mellitus. |
|
4 0С - 25 0С |
 |
General trade information |
|
Processing |
|
R-5651/07.08.2008 |
|
07/08/2008 |
|
GB12/86110 |
|
12/07/2017 |